High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel during August 2020-March 2021 Suggests Role for Improved Infection Control
Open Forum Infectious Diseases
; 8(SUPPL 1):S289-S290, 2021.
Article
in English
| EMBASE | ID: covidwho-1746619
ABSTRACT
Background. Peru has one of the highest per capita SARS-CoV-2 death rates in Latin America. Healthcare workers (HCW) are a critical workforce during the COVID-19 pandemic but are themselves often at increased risk of infection. We evaluated SARS-CoV-2 attack rate and risk factors among frontline HCWs. Methods. We performed a prospective cohort study of HCW serving two acute care hospitals in Lima, Peru from Aug 2020 to Mar 2021. Participants had baseline SARS-CoV-2 serology using the CDC ELISA, active symptom monitoring, and weekly respiratory specimen collection with COVID-19 exposure/risk assessment for 16-weeks regardless of symptoms. Respiratory specimens were tested by real-time reverse transcriptase PCR (rRT-PCR). Results. Of 783 eligible, 667 (85%) HCW were enrolled (33% nurse assistants, 29% non-clinical staff, 26% nurses, 7% physicians, and 6% other). At baseline and prior to COVID-19 vaccine introduction, 214 (32.1%;214/667) were reactive for SARS-CoV-2 antibodies. In total, 72 (10.8%;72/667) HCWs were found to be rRTPCR positive during weekly follow-up. Of the rRT-PCR positive HCWs, 37.5% (27/72) did not report symptoms within 1-week of specimen collection. During follow up, HCW without detectable SARS-CoV-2 antibodies at baseline were significantly more likely to be rRT-PCR positive (65/453, 14.3%) compared to those with SARS-CoV-2 antibodies at baseline (4/214, 1.9%) (p-value < 0.001). Three HCW were both serologically reactive and rRT-PCR positive at baseline. Looking only at HCW without SARS-CoV-2 antibodies, nurse assistants (rRT-PCR positive 18.6%;27/141) and non-clinical healthcare workers (16.5%;21/127) were at greater risk of infection compared to nurses (8.5%;10/118), physicians (7.9%;3/38), and other staff (10.3%;4/29) (RR 1.95;95%CI 1.2,3.3;p-value 0.01). Conclusion. Baseline SARS-CoV-2 prevalence and 16-week cumulative incidence were substantial in this pre-vaccination Peruvian HCW cohort. Almost 40% of new infections occurred in HCW without complaint of symptoms illustrating a limitation of symptom-based HCW screening for COVID-19 prevention. Nurse assistants and non-clinical healthcare workers were at greater risk of infection indicating a role for focused infection prevention and risk reduction strategies for some groups of HCW.
SARS-CoV-2 antibody; SARS-CoV-2 vaccine; adult; cohort analysis; conference abstract; controlled study; coronavirus disease 2019; cumulative incidence; emergency care; enzyme linked immunosorbent assay; female; follow up; health care personnel; human; human tissue; infection control; infection prevention; male; multicenter study; nonhuman; nurse; Peru; physician; prevalence; prevention; prospective study; real time reverse transcription polymerase chain reaction; risk assessment; risk factor; risk reduction; serology; Severe acute respiratory syndrome coronavirus 2; vaccination
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Open Forum Infectious Diseases
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS